A Relationship Between O-Serotype, Antibiotic Susceptibility and Biofilm Formation in Uropathogenic Escherichia coli

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Arezoo Noie OskouieElghar Soltani

Abstract

Uropathogenic Escherichia coli (UPEC) is a well-known pathogen that has perturbed the medical scenario because of its resistance to diverse therapeutic drugs and its ability to form a biofilm. Different O-serogroups are the prevalent cause of urinary tract infections (UTIs) along with their ability to form a biofilm. The present research aimed to assess antibiotic susceptibility, biofilm formation, and serotyping of UPEC isolates in conjunction with the demographic data. Antibiotic susceptibility was determined using the Kirby-Bauer method and biofilm formation was assessed phenotypically and at the molecular level. Serotyping was performed by multiplex PCR. A significant proportion of the total of 120 UPECs was isolated from women (p < 0.05). Most isolates were resistant to cefotaxime, ceftazidime, and tetracycline, but maintained their sensitivity to imipenem. O25, O15, O8, and O75 were the most commonly detected serogroups. Moreover, O25, O15, and O8 were the highest biofilm-producing serogroups among the UPEC isolates. Serogroups O75 and O21 were significantly associated with diabetic patients and subjects with renal disease, respectively (p < 0.05). Overall, our results show that UTI incidence in women should be a subject ...Continue Reading

References

Feb 1, 1976·Urology·W R FairN Wehner
Sep 3, 1999·Applied and Environmental Microbiology·J L Adams, R J McLean
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W WarrenW E Stamm
Mar 4, 2000·Journal of Microbiological Methods·S StepanovicM Svabic-Vlahovic
Aug 23, 2001·International Journal of Antimicrobial Agents·J A KarlowskyD F Sahm
Sep 7, 2001·Annual Review of Microbiology·M B Miller, B L Bassler
Jun 8, 2002·FEMS Microbiology Letters·F Paola Corona-Izquierdo, Jorge Membrillo-Hernández
Feb 3, 2004·Nature Biotechnology·Paul S Cremer
Mar 1, 2006·Indian Journal of Medical Sciences·Debasis BiswasAshish Kumar
Jun 30, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jaffar A Al-Tawfiq
Oct 6, 2006·Antonie van Leeuwenhoek·Anthony ColletPatrick Di Martino
May 23, 2007·Infection and Immunity·Erin C Hagan, Harry L T Mobley
Nov 6, 2007·Biotechnology and Bioengineering·Akinobu ItoSatoshi Okabe
Aug 16, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Safar FarajniaAilar Nakhlband
Oct 4, 2008·International Journal of Immunopathology and Pharmacology·C LonghiS Schippa
Jan 1, 2008·Journal of Infection in Developing Countries·Atul Kothari, Vishal Sagar
May 5, 2010·Journal of Infection in Developing Countries·Nasim KashefSahba Shahbazi
Apr 25, 2012·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Smita Sood, Ravi Gupta
May 1, 2013·Annals of Clinical Microbiology and Antimicrobials·Hassan MomtazNegar Souod
Apr 11, 2014·Iranian Red Crescent Medical Journal·Banafshe DormaneshEbrahim Khodaverdi Darian
Jan 22, 2015·Pathogens and Global Health·Seema MittalUma Chaudhary
Oct 5, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Gloria Luz Paniagua-ContrerasSergio Vaca
Dec 15, 2015·Acta biochimica Polonica·Wioletta Adamus-BiałekGrzegorz Czerwonka

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Serotyping

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.